The Appropriations Subcommittee has jurisdiction over HHS. APIC and SHEA submitted a joint testimony to the subcommittee recommending infection prevention program funding for fiscal year 2014. APIC and SHEA made the following funding requests:
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
• $27.5 million for the Centers for Disease Control and Prevention’s National Healthcare Safety Network and the Prevention Epicenters Program.
• $182.2 million for core infectious diseases, including funding for healthcare-associated infections, antimicrobial resistance and CDC’s Emerging Infections Program.
• $34 million for the Agency for Healthcare Research and Quality to reduce and prevent HAIs; specifically, $11.6 million in HAI research grants and $22.4 million in HAI contracts including the Comprehensive Unit-based Safety Program.
• $500 million annually for the National Institute of Allergy and Infectious Diseases’ antibacterial and related diagnostics efforts by the end of FY 2014. NIAID should invest at least $100 million annually in its new antibiotic-resistance focused clinical trials network, APIC and SHEA wrote.
More Articles on Infection Control:
Infection Control Market Expected to Reach $14B by 2017
NQF Endorses Infectious Disease, Neurological, Pulmonary Measures
5 Predictors of Infection From Antibiotic-Resistant Strain of E. Coli
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
